当前位置: X-MOL 学术 › Human Psychopharmacology: Clinical and Experimental › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Adiponectin predicts poor response to antidepressant drugs in major depressive disorder
Human Psychopharmacology: Clinical and Experimental ( IF 1.672 ) Pub Date : 2021-05-04 , DOI: 10.1002/hup.2793
Francesco Benedetti 1, 2 , Igor Branchi 3 , Sara Poletti 1, 2 , Cristina Lorenzi 1 , Giorgia Bigai 2 , Cristina Colombo 2, 4 , Raffaella Zanardi 2, 4
Affiliation  

Produced by adipocytes, adiponectin crosses the blood-brain barrier to bind with specific receptors in the hypothalamus, brainstem, hippocampus, and cortex. In patients with major depressive disorder (MDD), circulating levels of adiponectin inversely related with antidepressant response to ketamine, and predicted a better response to multi-target drug combinations than to escitalopram. We investigated the effect of adiponectin on response to antidepressants in a naturalistic setting.

中文翻译:

脂联素可预测重度抑郁症患者对抗抑郁药的不良反应

脂联素由脂肪细胞产生,穿过血脑屏障与下丘脑、脑干、海马和皮层中的特定受体结合。在重度抑郁症 (MDD) 患者中,脂联素的循环水平与对氯胺酮的抗抑郁反应呈负相关,并预测对多靶点药物组合的反应优于依他普仑。我们在自然环境中研究了脂联素对抗抑郁药反应的影响。
更新日期:2021-05-04
down
wechat
bug